Lung Technologies

Lung Technologies - Incentive Spirometer

Pulmonary Atelectasis, fever and pneumonia are common and costly post-surgical complications today. Current treatments include an Incentive Spirometer given to the patient. The problem is that the patient does not use it as prescribed or does not use it correctly so their lung alveoli are not re-expanding after surgery causing pulmonary atelectasis. Today, there is no way to monitor a patient's Incentive Spirometer use. Lung Technologies is gearing up to change that with an all new digital user-interface on the Spirometer as well as a re-design of the Spirometer to add additional features asked for by respiratory therapists and pulmonologists. Current Incentive Spirometers have been around for 30 years and have not changed or improved at all. Covid-19 brought to light the importance of good and strong lung alveoli health. Covid-19 attacked the lung alveoli and an Incentive Spirometer was prescribed to patients with Covid-19 to improve their pulmonary function. This student team worked to not only bring an Incentive Spirometer up to modern standards, but to completely re-design the Incentive Spirometer with a fully functioning prototype to include a new and first of its kind digital user-interface. This student team also worked to add additional features that respiratory care wants, including aerosol attachment capabilities. This student team worked in Solidworks and through other engineering software to be able to take it to industry for manufacturing and licensing deals.

Related News